HIP
PFE icon

HUB Investment Partners’s Pfizer PFE Stock Holding History

HUB Investment Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.1K Hold
1,000
– – ﹤0.01% 1123
2025
Q4 		$24.9K Buy
+1,000
New +$25.2K ﹤0.01% 944
2023
Q4 		– Sell
-100
Closed -$3.32K – 421
2023
Q3 		$3.32K Buy
+100
New +$3.54K ﹤0.01% 268

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

HUB Investment Partners's PFE Position: Q1 2026 in Review

HUB Investment Partners increased its Pfizer (PFE) stake by 5.2% in Q1 2026, buying an estimated $203K and bringing the position to 154,351 shares worth $4.33M. The position accounts for 0.1% of the portfolio, ranked #171.

HUB Investment Partners first reported a position in PFE in Q4 2020 and has held it in 21 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • HUB Investment Partners held 154,351 shares of Pfizer worth $4.33M as of Q1 2026.
  • HUB Investment Partners bought 7,639 Pfizer shares in Q1 2026, an estimated $203K.
  • Pfizer made up 0.1% of HUB Investment Partners's portfolio in Q1 2026, its #171 holding.
  • HUB Investment Partners first reported a position in Pfizer in Q4 2020 and has held it in 21 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on HUB Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.